Evidence map›Paper›PMID 24014879›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Katerina Oikonomopoulou, Robert A DeAngelis, Hui Chen, Eleftherios P Diamandis, Morley D Hollenberg, Daniel Ricklin, John D Lambris

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Katerina OikonomopoulouDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Robert A DeAngelis
Hui Chen
Eleftherios P Diamandis
Morley D Hollenberg
Daniel Ricklin
John D Lambris
University of Pennsylvania · USMount Sinai Hospital · CAUniversity of Calgary · CA

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
STRUCTURE-FUNCTION ANALYSIS OF DIFFERENT C3 SPECIESR01AI030040 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 1993 to 2016
$4.1M
Complement inhibition as sepsis therapyR01GM097747 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LAMBRIS, JOHN D, LUPU, FLOREA · 2011 to 2014
$2.1M
Thermodynamic and structural studies on the formation of the C3 convertaseR01AI072106 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2011
$2.0M
Complement in AMD: Mechanisms and Therapeutic InterventionR01EY020633 · NEI · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2011 to 2013
$1.8M
A novel approach for assessing dynamic events in the human complement systemR21AI097805 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI RICKLIN, DANIEL · 2012 to 2013
$426k
VIRAL RESPIRATORY PATHOGENS RESEARCH UNIT /VRPRU/-266030040-266030040N01AI030040 · NIAID · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2003 to 2006
–
CIHRNEI NIH HHS EY020633NEI NIH HHS R01 EY020633NIAID NIH HHS AI068730NIAID NIH HHS AI072106NIAID NIH HHS AI097805NIAID NIH HHS N01 AI030040NIAID NIH HHS P01 AI068730NIAID NIH HHS R01 AI030040NIAID NIH HHS R01 AI072106NIAID NIH HHS R21 AI097805NIGMS NIH HHS GM097747NIGMS NIH HHS R01 GM097747
6 · The paper itself

Abstract

Activation of the complement system is primarily initiated by pathogen- and damage-associated molecular patterns on cellular surfaces. However, there is increasing evidence for direct activation of individual complement components by extrinsic proteinases as part of an intricate crosstalk between physiological effector systems. We hypothesized that kallikrein-related peptidases (KLKs), previously known to regulate inflammation via proteinase-activated receptors, can also play a substantial role in innate immune responses via complement. Indeed, KLKs exemplified by KLK14 were efficiently able to cleave C3, the point of convergence of the complement cascade, indicating a potential modulation of C3-mediated functions. By using in vitro fragmentation assays, mass spectrometric analysis, and cell signaling measurements, we pinpointed the generation of the C3a fragment of C3 as a product with potential biological activity released by the proteolytic action of KLK14. Using mice with various complement deficiencies, we demonstrated that the intraplantar administration of KLK14 results in C3-associated paw edema. The edema response was dependent on the presence of the receptor for C3a but was not associated with the receptor for the downstream complement effector C5a. Our findings point to C3 as one of the potential substrates of KLKs during inflammation. Given the wide distribution of the KLKs in tissues and biological fluids where complement components may also be expressed, we suggest that via C3 processing, tissue-localized KLKs can play an extrinsic complement-related role during activation of the innate immune response.

Indexed as

AnimalsComplement ActivationComplement C3Complement C3aComplement C5Disease Models, AnimalEdemaHumansKallikreinsMiceMice, KnockoutProteolysisReceptors, ComplementComplement C3Complement C3acomplement C3a receptorComplement C5KallikreinsKLK14 protein, humanReceptors, Complement

Identifiers

PMID24014879
PMCPMC3922206
OpenAlexW2120807508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.